Tuberculosis News and Research

Latest Tuberculosis News and Research

UNITAID working with travel web sites to raise donations for HIV/AIDS, tuberculosis and malaria

Philippe Douste-Blazy, former French foreign minister and head of UNITAID, announced recently that he is in talks with online travel industry CEOs to allow air travelers booking online to make a $2 per-flight donation to HIV/AIDS, tuberculosis and malaria efforts worldwide, the Financial Times reports.

16 Mar 2009

Breakthrough improves effectiveness of tuberculosis vaccine

A breakthrough strategy to improve the effectiveness of the only tuberculosis vaccine approved for humans provided superior protection against the deadly disease in a pre-clinical test, report scientists at The University of Texas Health Science Center at Houston in Nature Medicine 's Advance Online Publication March 1.

8 Mar 2009

Long-defunct gene comes back to life in humans

Researchers have discovered that a long-defunct gene was resurrected during the course of human evolution.

8 Mar 2009

Botswana to implement pilot HIV/TB program, redesign malaria program

Botswana's Health Minister Lesego Motsumi on Monday presented a pilot program to address HIV/tuberculosis coinfection and support health workers who are treating patients with HIV/TB coinfection, Mmegi reports.

5 Mar 2009

Contra Costa County considering health services cuts for undocumented immigrants, inmates

This month, the Contra Costa County, Calif., Board of Supervisors will consider a plan to prohibit undocumented adult immigrants from receiving nonurgent, county-funded care, the Contra Costa Times reports.

4 Mar 2009

Zambia launches effort to improve tuberculosis diagnosis

Zambia recently launched a four-year project to improve tuberculosis diagnosis and ensure early treatment for the disease, the Daily Mail reports.

4 Mar 2009

Advocates in Mexico call for greater effort against HIV/AIDS

AIDS-related mortality rates in Mexico have remained somewhat steady over the past 12 years, despite increased access to antiretroviral drugs in the country, officials at the National Institute of Public Health, or INSP, said recently, The News/Individual.com reports.

4 Mar 2009

Tuberculosis breakthrough could lead to stronger vaccine

3 Mar 2009

Doctors call for change in how non-active tuberculosis in immigrant children treated

New guidelines proposed in the March 2009 issue of the journal Pediatrics by researchers from the Indiana University School of Medicine and Riley Hospital for Children may have a major impact on how pediatricians and family physicians treat non-active tuberculosis (TB) in children who are immigrants, internationally adopted or refugees.

2 Mar 2009

New discovery improves efficacy of current tuberculosis vaccine

A new article appearing in the March 2009 issue of the Journal of Leukocyte Biology may lead to improvements in the efficacy of the current tuberculosis vaccine.

26 Feb 2009

Lab tests show meropenem and clavulanate combination effective against drug-resistant TB bacteria

WHAT: In a finding that could soon help people infected with untreatable, highly drug-resistant tuberculosis (TB), scientists have shown that two FDA-approved drugs work in tandem to kill laboratory-grown strains of Mycobacterium tuberculosis (Mtb), the bacterium that causes TB.

26 Feb 2009

Drug combo shows potential for treating extensively drug resistant tuberculosis

A combination of two FDA-approved drugs, already approved for fighting other bacterial infections, shows potential for treating extensively drug resistant tuberculosis (XDR-TB), the most deadly form of the infection.

26 Feb 2009

Global AIDS Alliance sounds alarm on potential budget cuts

Amid initial indications that the administration's first budget will flat-line funding for global health, the Global AIDS Alliance is calling on President Obama, Vice President Biden and Secretary of State Hillary Clinton to keep their campaign commitments to scale up the President's Emergency Plan for AIDS Relief (PEPFAR) and accelerate efforts to ensure every child around the world gets a free basic education.

23 Feb 2009

Questions of ethics and quality cloud globalization of clinical trials

Top-tier U.S.-based pharmaceutical companies are moving their clinical trials overseas at warp speed, raising questions about ethics, quality control, and even the scientific value of their findings for people back in the U.S.

20 Feb 2009

Personal digital assistants used to track tuberculosis data

For patients who have drug-resistant forms of tuberculosis, it's critical to monitor the disease as closely as possible.

11 Feb 2009

Study on ustekinumab for treatment of psoriatic arthritis published

A group of patients suffering from potentially debilitating psoriatic arthritis showed significant and prolonged improvement after treatment with ustekinumab, according to data from a randomized, double-blind, placebo-controlled study in patients with moderate to severe psoriatic arthritis (PsA).

11 Feb 2009

Long-sought protein structure may help reveal how ‘gene switch’ works

The bacterium behind one of mankind's deadliest scourges, tuberculosis, is helping researchers at the Commerce Department's National Institute of Standards and Technology (NIST) and the Department of Energy's Brookhaven National Laboratory (BNL) move closer to answering the decades-old question of what controls the switching on and off of genes that carry out all of life's functions.

10 Feb 2009

Long-sought protein structure may help reveal how 'gene switch' works

8 Feb 2009

Robot scientist promises to dig up new drugs

A robot scientist that can make informed guesses about how effective different chemical compounds will be at fighting different diseases could revolutionise the pharmaceutical industry by developing more effective treatments more cheaply and quickly than current methods.

3 Feb 2009

Century old drug clofazimine shows potential for multiple sclerosis

A century-old drug that failed in its original intent to treat tuberculosis but has worked well as an antileprosy medicine now holds new promise as a potential therapy for multiple sclerosis and other autoimmune diseases.

2 Feb 2009